NuCana plc Overview
NuCana plc (NCNA) has a P/E ratio of -0.33, below the Healthcare sector average of 24.78.
Get informed when a big investor buys or sells
+ Follow-0.33
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
NuCana plc (NCNA) currently reports a P/E ratio of -0.33. That is below the Healthcare sector average of 24.78. Use the charts on this page to explore NuCana plc's P/E ratio history and peer comparisons.
NuCana plc's P/E ratio of -0.33 is lower than the Healthcare sector average of 24.78. That is roughly 101.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates NuCana plc's market price to a fundamental measure such as earnings, sales, or book value. At -0.33, NCNA can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of -0.33, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 24.78. From there, open related valuation or income-statement pages for NuCana plc, and consider following NCNA for alerts when major investors trade the stock.
NuCana plc is classified in the Healthcare sector. On P/E ratio, it currently shows -0.33 versus a sector average near 24.78. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NCNA with unrelated industries.
